Enveric Biosciences Statistics
Total Valuation
ENVB has a market cap or net worth of $2.84 million. The enterprise value is -$990,827.
Important Dates
The next estimated earnings date is Friday, March 27, 2026, before market open.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENVB has 1.39 million shares outstanding. The number of shares has increased by 484.62% in one year.
| Current Share Class | 1.39M |
| Shares Outstanding | 1.39M |
| Shares Change (YoY) | +484.62% |
| Shares Change (QoQ) | +44.81% |
| Owned by Insiders (%) | 2.85% |
| Owned by Institutions (%) | 6.09% |
| Float | 1.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.60
| Current Ratio | 4.60 |
| Quick Ratio | 4.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -120,424.09 |
Financial Efficiency
Return on equity (ROE) is -262.78% and return on invested capital (ROIC) is -164.61%.
| Return on Equity (ROE) | -262.78% |
| Return on Assets (ROA) | -133.22% |
| Return on Invested Capital (ROIC) | -164.61% |
| Return on Capital Employed (ROCE) | -282.23% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.87M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENVB has paid $7,199 in taxes.
| Income Tax | 7,199 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.17% in the last 52 weeks. The beta is 0.30, so ENVB's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -90.17% |
| 50-Day Moving Average | 2.87 |
| 200-Day Moving Average | 8.59 |
| Relative Strength Index (RSI) | 39.42 |
| Average Volume (20 Days) | 990,474 |
Short Selling Information
The latest short interest is 118,369, so 8.51% of the outstanding shares have been sold short.
| Short Interest | 118,369 |
| Short Previous Month | 62,034 |
| Short % of Shares Out | 8.51% |
| Short % of Float | 9.31% |
| Short Ratio (days to cover) | 0.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.75M |
| Pretax Income | -9.73M |
| Net Income | -11.25M |
| EBITDA | -9.51M |
| EBIT | -9.75M |
| Earnings Per Share (EPS) | -$61.29 |
Full Income StatementBalance Sheet
The company has $3.76 million in cash and n/a in debt, with a net cash position of $3.76 million or $2.70 per share.
| Cash & Cash Equivalents | 3.76M |
| Total Debt | n/a |
| Net Cash | 3.76M |
| Net Cash Per Share | $2.70 |
| Equity (Book Value) | 3.46M |
| Book Value Per Share | 6.67 |
| Working Capital | 3.26M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.67M |
| FCF Per Share | -$5.52 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
